newsfilter
← Latest News
PR Newswire·

PTC Therapeutics Provides Regulatory Update on Translarna™

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for Translarna™ (ataluren)...